(S1 (S (NP (NP (DT A) (NN cell) (NN culture) (NN system)) (VP (TO to) (VP (VB monitor) (NP (NN effector) (NN CTL) (NN differentiation)))))))
(S1 (S (S (NP (PRP We)) (VP (VBD used) (NP (DT a) (JJ simple) (NN cell) (NN culture) (NN system)) (S (VP (TO to) (VP (VB examine) (NP (NP (DT the) (NNS kinetics)) (PP (IN of) (NP (NN effector) (NN gene) (NN expression)))) (PP (IN during) (NP (JJ CD8+) (NN T) (NN cell) (NN differentiation)))))))) (. .)))
(S1 (S (S (NP (NP (JJ Naive) (JJ CD8+) (NN T) (NNS cells)) (PP (IN from) (NP (NN P14) (NN TCR) (JJ transgenic) (NNS mice)))) (VP (VP (VBD were) (VP (VBN activated) (PP (IN for) (NP (NP (CD 2) (NN d)) (PP (PP (IN with) (NP (NP (ADJP (JJ anti-CD3))) (CC and) (NP (ADJP (JJ anti-CD28))))) (CC or) (PP (IN with) (NP (JJ splenic) (NNS APCs)))))) (PP (IN in) (NP (NP (DT the) (NN presence)) (PP (IN of) (NP (NN Gp33) (NN peptide))))))) (, ,) (CC and) (VP (VBD were) (VP (VBN cultured) (PP (IN in) (NP (NP (NNS media)) (VP (VBG containing) (NP (NP (CD 100) (NN U/ml)) (PP (IN of) (NP (NP (JJ recombinant) (JJ human) (NN IL-2)) (PRN (-LRB- -LRB-) (NP (NN rhIL-2)) (-RRB- -RRB-)))))))))))) (. .)))
(S1 (S (NP (PRP We)) (VP (VBD used) (NP (NN TCR) (JJ transgenic) (NNS mice)) (PP (IN for) (NP (DT these) (NNS experiments))) (SBAR (IN because) (S (S (NP (PRP they)) (VP (VBP provide) (NP (NP (DT a) (JJ reliable) (NN source)) (PP (IN of) (NP (JJ CD8+) (NN T) (NNS cells))) (SBAR (WHNP (WDT that)) (S (VP (VBP are) (ADJP (RB truly) (JJ naive)))))))) (: ;) (S (ADVP (RB however)) (, ,) (NP (PRP we)) (VP (VBP chose) (S (VP (RB not) (TO to) (VP (VB stimulate) (NP (NP (NNS cells)) (PP (IN with) (NP (NN antigen)))) (PP (IN in) (NP (NP (JJS most) (NNS experiments)) (SBAR (ADVP (RB so) (RB as)) (S (VP (TO to) (VP (VB avoid) (NP (NP (NN contamination)) (PP (IN with) (NP (NP (NP (NNS proteins)) (CC and) (NP (JJ nucleic) (NNS acids))) (VP (VBN derived) (PP (IN from) (NP (NNS APCs))))))))))))))))))))) (. .)))
(S1 (S (S (S (NP (EX There)) (VP (VBD were) (NP (NP (ADJP (RB only) (JJ minor)) (NNS differences)) (PP (IN in) (NP (NN gene) (NN expression)))) (PP (IN during) (NP (NP (NN differentiation)) (VP (VBN induced) (PP (IN by) (NP (NP (NN antigen/APC)) (CC versus) (NP (ADJP (JJ anti-CD3/anti-CD28)))))))))) (, ,) (CC and) (S (NP (NP (DT the) (JJ major) (NNS conclusions)) (VP (VBN presented) (PP (IN in) (NP (DT this) (NN report))))) (VP (VBP are) (NP (NP (DT the) (JJ same)) (PP (IN for) (NP (DT both) (VBG activating) (NNS conditions))))))) (. .)))
(S1 (S (S (PP (IN Under) (NP (PRP$ our) (NN culture) (NNS conditions))) (, ,) (NP (VBN activated) (JJ CD8+) (NN T) (NNS cells)) (VP (VP (VBD expanded) (ADVP (RB exponentially))) (CC and) (VP (VBD accumulated) (PP (IN for) (NP (QP (RB >) (CD 8)) (NN d)))))) (. .)))
(S1 (S (S (NP (PRP We)) (VP (VBN limited) (NP (PRP$ our) (NN analysis)) (PP (TO to) (NP (NP (DT the) (JJ first) (CD 6-8) (NN d)) (PP (IN after) (NP (NP (NN activation)) (, ,) (NP (NP (DT a) (NN period)) (SBAR (WHNP (WDT that)) (S (VP (VBZ coincides) (PP (IN with) (NP (NP (JJ clonal) (NN expansion)) (PP (IN of) (NP (JJ CD8+) (NN T) (NNS cells))) (PP (IN after) (NP (NP (NN activation)) (ADVP (FW in) (FW vivo)))))))))))))))) (. .)))
